SEC Tracker
Get the app

Innovative Eyewear LUCY

Innovative Eyewear FY 2024: revenue $1.6M, up 42%; diluted EPS −$5.19

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Innovative Eyewear reported for the year ended Dec 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$1.6M+42% from $1.2M in FY 202310-K income statement, on EDGAR
  2. Net income−$7.8MAgainst −$6.7M in FY 202310-K income statement, on EDGAR
  3. Diluted EPS−$5.19Against −$0.63 in FY 202310-K income statement, on EDGAR
  4. Cash and cash equivalents$2.6M−39% from $4.3M in FY 2023Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations−$6.7MAgainst −$5.8M in FY 202310-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Innovative Eyewear files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3851 and related industry codes: the same peer list as the financial tables.

  1. RxSight RXST public float $504M, Jun 30, 2025
  2. Bausch & Lomb BLCO public float $557M, Jun 30, 2025
  3. Staar Surgical STAA public float $884M, Jun 27, 2025
  4. National Vision Holdings EYE public float $1.3B, Jun 28, 2025
  5. Warby Parker WRBY public float $2.2B, Jun 30, 2025